KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $200.2 million.

  • Biogen's Depreciation & Amortization (CF) rose 880.43% to $200.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $779.9 million, marking a year-over-year increase of 1584.97%. This contributed to the annual value of $779.9 million for FY2025, which is 1584.97% up from last year.
  • As of Q4 2025, Biogen's Depreciation & Amortization (CF) stood at $200.2 million, which was up 880.43% from $202.2 million recorded in Q3 2025.
  • In the past 5 years, Biogen's Depreciation & Amortization (CF) ranged from a high of $202.2 million in Q3 2025 and a low of $102.6 million during Q1 2021
  • Its 5-year average for Depreciation & Amortization (CF) is $147.7 million, with a median of $137.4 million in 2022.
  • Per our database at Business Quant, Biogen's Depreciation & Amortization (CF) crashed by 2152.34% in 2023 and then soared by 4624.0% in 2024.
  • Quarter analysis of 5 years shows Biogen's Depreciation & Amortization (CF) stood at $134.7 million in 2021, then dropped by 11.06% to $119.8 million in 2022, then grew by 16.94% to $140.1 million in 2023, then skyrocketed by 31.33% to $184.0 million in 2024, then grew by 8.8% to $200.2 million in 2025.
  • Its last three reported values are $200.2 million in Q4 2025, $202.2 million for Q3 2025, and $194.3 million during Q2 2025.